![\"69553052\"](\"http:\/\/cannachronicle.com\/wp-content\/uploads\/2016\/07\/69553052.jpg\")
<\/p>\nThe history of cannabis dates back thousands of years; from the ancient Chinese medicines to George\u00a0Washington\u2019s hemp plants, cannabis has found a place in many chapters of history books.<\/p>\n
Currently, 25 states and the District of Columbia have legalized medical cannabis and four states have\u00a0legalized recreational cannabis.<\/p>\n
<\/p>\n
The state of the global economy has caused world-renowned investors and economists to expect a\u00a0recession within the next year. At the same time, an increased amount of capital continues to enter the\u00a0cannabis industry. This amount of money entering the industry is not only larger but smarter too; these\u00a0investors and firms are long-term holders that see the bigger picture.<\/p>\n
The reason for the increased amount of capital entering the industry is simple\u2026cannabis companies are\u00a0pretty much recession proof because:<\/p>\n
1) They do not get the same benefits as other industries (such as access to bank accounts)<\/p>\n
2) People will continue to use cannabis and cannabis-based medicines during a recession (just like\u00a0beer and cigarettes)<\/p>\n
When it comes to investing, and in particular in cannabis stocks, there are two main rules that we\u00a0recommend you follow: 1) Be selective, and 2) Timing is everything.<\/p>\n
Not only has the amount capital entering the cannabis industry increased. During the last two years, we\u00a0have continued to see more states legalize medical cannabis, while the amount of clinical data and\u00a0support from high ranking individuals and organizations supporting medical cannabis increased\u00a0significantly. Highlights include:<\/p>\n
1. Sanjay Gupta, CNN's medical guru and a renowned neurosurgeon who previously spoke out\u00a0against legal medical cannabis, wrote an article called, Why I Changed my Mind on Weed, in\u00a0which he apologized for his previously negative stance toward cannabis.<\/p>\n
2. In April 2015, the National Institute on Drug Abuse said cannabis can kill certain cancer cells.<\/p>\n
3. Last year, Surgeon General Vivek Murthy said, \u201cwe have some preliminary data showing that\u00a0for certain medical conditions and symptoms, cannabis can be helpful.\u201d<\/p>\n
4. In March 2016, GW Pharmaceuticals plc (GWPH) reported positive data from a Phase 3 trial\u00a0of Epidiolex for the treatment of Dravet syndrome.<\/p>\n
5. In June, GWPH reported positive results of the first Phase 3 clinical trial of Epidiolex for the\u00a0treatment of Lennox-Gastaut syndrome (LGS).<\/p>\n
Although the opinions of the Surgeon General, the National Institute on Drug Abuse, and the National\u00a0Institute of Health were not enough to remove cannabis from its Schedule I classification, recent clinical\u00a0evidence is hard to ignore.<\/p>\n
Cannabis companies saw tremendous growth in early 2014; however, that was just the beginning.\u00a0The massive influx of cannabis companies going public over the past 18 months coupled with an\u00a0increased amount of SEC trading suspensions caused the industry to see sell-off as capital exited stocks.<\/p>\n
Currently, there are more than 300 publicly traded cannabis companies and we expect less than 10% to\u00a0still be in business in three years.<\/p>\n
Many cannabis companies are in their developmental stage and are thus naturally speculative in nature.\u00a0With big risk comes big reward however, investors must be selective and do their due diligence before\u00a0investing.<\/p>\n
The second annual Cannabis Investing Event is being co-located at The MoneyShow San Francisco,\u00a0taking place at the Marriott Marquis on August 23 rd to August 25 th .<\/p>\n
Five Ways Cannabis Investors Benefit from Industry Experts for FREE!<\/p>\n
1. Gather actionable investing advice from leading analysts in the cannabis industry<\/p>\n
2. Interact with leading cannabis executives during the conference<\/p>\n
3. Discover new investment opportunities in the cannabis industry<\/p>\n
4. Learn about privately held cannabis companies that plan to go public during the next year<\/p>\n
5. Receive a free copy of the 2016 Cannabis Industry Report ($189 value)!<\/p>\n
This must attend conference will include presentations from\u00a0Isaac Dietrich<\/a> of MassRoots<\/a>, Tom Quigley<\/a> of The Gluu<\/a>,\u00a0Cam Battley<\/a>,\u00a0Brett Roper<\/a>,\u00a0Troy Dayton<\/a>,\u00a0Adam Cohen<\/a> of\u00a0MJardin<\/a>,\u00a0Jim McAlpine<\/a>,\u00a0Derek Thomas<\/a>,\u00a0Matt Karnes<\/a>\u00a0and Jason Spatafora<\/a><\/p>\n
![\"RACE-click-here-to-register\"](\"http:\/\/cannachronicle.com\/wp-content\/uploads\/2016\/07\/RACE-click-here-to-register.jpg\")
<\/a><\/p>\n